Cannara Biotech Inc. (LOVFF)
| Market Cap | 93.77M |
| Revenue (ttm) | 62.29M |
| Net Income (ttm) | 4.74M |
| Shares Out | n/a |
| EPS (ttm) | 0.05 |
| PE Ratio | 19.79 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 16,249 |
| Average Volume | 10,501 |
| Open | 1.020 |
| Previous Close | 1.010 |
| Day's Range | 1.013 - 1.020 |
| 52-Week Range | 0.387 - 0.990 |
| Beta | 0.80 |
| RSI | 64.40 |
| Earnings Date | Apr 28, 2025 |
About Cannara Biotech
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada. [Read more]
Full Company ProfileFinancial Performance
In 2024, Cannara Biotech's revenue was 81.75 million, an increase of 42.77% compared to the previous year's 57.26 million. Earnings were 6.44 million, a decrease of -7.30%.
Financial numbers in CAD Financial StatementsNews
Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors
Cannara Biotech appoints Justin Cohen to its Board of Directors, enhancing brand strategy with his extensive marketing and digital transformation expertise
Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike
Cannara announces its 2024 AGM will be virtual. Due to a postal strike. Proxy materials are online, and exemptions apply under CSA Blanket Order 51-913
Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024
MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) ( TSXV: LOVE) ( OTCQB: LOVFF) ( FRA: 8CB0), a vertically integrated producer of premium-gra...
Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market
Record Q4 and year-end total revenues of $23.4 million and $82.2 million, representing a 28% and 43% increase compared to the same periods in 2023. Robust growth in Q4 over Q3 2024, with total revenue...
Cannara Biotech Reports Q3 2024 Financial Results
Net revenues up 22.6% to $19.5M, positive Adjusted EBITDA of $2.8M and operating cash flows of $4.3 million. Focused on the Canadian Cannabis Opportunity
Cannara Biotech Reports Q2 2024 Financial Results
Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4.0 million ...
Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion
Record Q1 net revenues of $19.5 million, representing an 89% increase compared to the $10.3 million of net revenues generated in Q1 2023 Q1 operating income of $3.4 million, representing an 201% incre...
Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")
MONTREAL , Jan. 8, 2024 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivati...
Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January 25th, 2024
MONTREAL , Dec. 13, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivat...
Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023
MONTREAL , Dec. 11, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivat...
Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues
Record Q4 and year end net revenues of $18.3 million and $57.6 million, representing a 53% and 60% increase compared to the same periods of 2022 Sequentially, Q4 showed significant growth over Q3 2023...
Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million
Three- and nine-month net revenue were $15.9 million and $39.3 million, a 57% and 63% increase compared to the same periods of prior year Delivered its ninth consecutive quarter of positive Adjusted E...
Cannara Biotech Inc Announces Participation in the LD Micro Invitational XIII
Montreal, Quebec--(Newsfile Corp. - May 23, 2023) - Cannara Biotech Inc (TSXV: LOVE) announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Ho...
Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference
MONTREAL , May 11, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivati...
CANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKING
MONTREAL , May 4, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivativ...
Cannara Biotech Inc. to Host Investor Webcast on May 4th, 2023
MONTREAL , April 25, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and deriva...
Cannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022
Six-month net revenues of $23.4 million, a 67% increase compared to first half 2022 Delivered its eighth consecutive quarter of positive Adjusted EBITDA of $3.2M, a 1500% increase compared to Q2 2022 ...
Cannara Biotech Inc. Enters into an Automatic Share Purchase Plan
MONTREAL , Feb. 28, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivat...
CANNARA BIOTECH INC. ANNOUNCES RESULTS OF ANNUAL SHAREHOLDER MEETING AND CONVERSION INTO EQUITY OF A $5M CONVERTIBLE DEBENTURE AT $0.18 CENT PER COMMON SHARE
MONTREAL , Feb. 10, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivat...
Cannara Biotech Inc. Reports Q1 2023 Financial Results
Company recorded $10.3 million in quarterly revenue; a 57% increase compared to Q1 2022 Delivered its seventh consecutive quarter of positive Adjusted EBITDA of $1.7M and reported positive net income ...
Cannara Announces Proposed Share Consolidation
MONTREAL , Jan. 12, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivat...
Cannara Announces Normal Course Issuer Bid for Common Shares of the Corporation
MONTREAL , Nov. 30, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivat...
Cannara Biotech Inc. Reports Record Q4 and 2022 Fiscal Year Financial Results
Company recorded a record high of $12 million in quarterly revenue (84% YoY increase) and Net Income of $2.6 million Full year revenues were $36 million, a 108% increase compared to 2021 Delivered its...
Cannara Releases 14 New SKU's Across Ontario and Quebec
MONTREAL , Sept. 30, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a Quebec-based, vertically integrated producer of premium-grade cann...
Cannara Biotech Inc. Announces Entry into the British Columbia Market and the Launch of its First Vape Cartridge and Vape Accessory, Tribal G Mint and UNI Pro Ark
MONTREAL , Sept. 20, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a Quebec-based, vertically integrated producer of premium-grade canna...